文献速递胃肠外科急腹症与外科感染

梗阻性左半结肠癌的术前支架治疗:全国性分析

Preoperative stents for the treatment of obstructing left-sided colon cancer: a national analysis.
PubMed 文献 · Surg Endosc · 2022-10-11

该研究基于2010-2016年全国再入院数据库,分析因恶性左半/乙状结肠梗阻行结肠支架或结肠切除术的成人患者。结肠支架使用率从7.7%升至16.4%(p<0.001)。风险调整后,支架桥接手术与造口率降低相关(OR 0.34,95%CI 0.24-0.46),死亡率和并发症风险相似。

要点

  • 结肠支架作为桥接手术的使用率逐年增加,2010至2016年从7.7%升至16.4%。
  • 支架桥接手术组造口率显著低于即刻手术组(21.5% vs 53.0%)。
  • 风险调整后支架与造口风险降低相关(OR 0.34),死亡和并发症无差异。

核心结论

  • 对于恶性左半结肠梗阻,结肠支架作为桥接手术与较低造口率相关,且死亡率和并发症与即刻手术相当。

研究设计与样本

  • 回顾性队列研究,使用2010-2016年全国再入院数据库,纳入9706例因恶性左半/乙状结肠梗阻行结肠支架或结肠切除术的成人患者。

主要发现

  • 9.7%的患者接受了结肠支架,使用率从2010年的7.7%上升至2016年的16.4%(p<0.001)。
  • 与即刻切除组相比,延迟切除组(支架后手术)患者更年轻(63.9 vs 65.9岁,p=0.04),合并症更少(Elixhauser指数3.5 vs 3.9,p=0.001),更多在高容量中心治疗(89.4% vs 68.1%,p<0.001)。
  • 延迟切除组腹腔镜切除比例更高(33.1% vs 13.0%,p<0.001),造口率显著更低(21.5% vs 53.0%,p<0.001)。
  • 风险调整后,结肠支架与造口风险降低相关(OR 0.34,95%CI 0.24-0.46),死亡率和并发症风险相似。

临床怎么用

  • 对于临床合适的恶性左半结肠梗阻患者,可考虑术前结肠支架作为桥接手术以降低造口率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Given the risks associated with urgent colectomy for large bowel obstruction, preoperative colonic stenting has been utilized for decompression and optimization prior to surgery. This study examined national trends in the use of colonic stenting as a bridge to resection for malignant large bowel obstruction and evaluated outcomes relative to immediate colectomy. METHODS: Adults undergoing colonic stenting or colectomy for malignant, left/sigmoid large bowel obstruction were identified in the 2010-2016 Nationwide Readmissions Database. Patients were classified as immediate resection (IR) or delayed resection (DR) if undergoing colonic stenting prior to colectomy. Generalized linear models were used to evaluate the impact of resection strategy on ostomy creation, in-hospital mortality, and complications. RESULTS: Among 9,706 patients, 9.7% underwent colonic stenting, which increased from 7.7 to 16.4% from 2010 to 2016 (p < 0.001). Compared to IR, the DR group was younger (63.9 vs 65.9 years, p = 0.04), had fewer comorbidities (Elixhauser Index 3.5 vs 3.9, p = 0.001), and was more commonly managed at high-volume centers (89.4% vs 68.1%, p < 0.001). Laparoscopic resections were more frequent among the DR group (33.1% vs 13.0%, p < 0.001), while ostomy rates were significantly lower (21.5% vs 53.0%, p < 0.001). After risk adjustment, colonic stenting was associated with reduced odds of ostomy creation (0.34, 95% confidence interval 0.24-0.46), but similar odds of mortality and complications. CONCLUSION: Colonic stenting is increasingly utilized for malignant, left-sided bowel obstructions, and associated with lower ostomy rates but comparable clinical outcomes. These findings suggest the relative safety of colonic stenting for malignant large bowel obstruction when clinically appropriate.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Hadaya J, Verma A, Sanaiha Y, et al. Preoperative stents for the treatment of obstructing left-sided colon cancer: a national analysis. Surg Endosc. 2022. PMID: 36220989. doi:10.1007/s00464-022-09650-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。